AGRICHEMICAL giant Bayer has stressed that it stands behind the safety of glyphosate and will continue to vigorously defend its glyphosate-based products, despite their political unpopularity.

To that end, it has just made 107 Bayer-owned glyphosate safety study reports openly available, in the hope of encouraging a 'science-based discussion' with regulators around the globe, as well as with consumers concerned about the safety of the substance.

"The company is working diligently to ensure the conversation around glyphosate is accurate and will continue to share information on the strong body of science that confirms glyphosate and glyphosate-based products are safe when used as directed and that glyphosate does not cause cancer," said Bayer this week, as it released the research accumulated by Monsanto before its takeover by the German firm.

These safety study reports were originally submitted to the European Food Safety Authority as part of the substance authorization process in the European Union, and are now accessible on Bayer’s 'dedicated transparency' platform.

“Transparency is a catalyst for trust, so more transparency is a good thing for consumers, policymakers and businesses," said Liam Condon, president of Bayer's crop science division. "As an innovation company, safety is our top priority and we are completely committed to doing everything we can to ensure that our products are safe for people and the environment.

“By making our detailed scientific safety data available, we encourage anyone interested to see for themselves how comprehensive our approach to safety is. We embrace the opportunity to engage in dialogue so we can build more trust in sound science.”